Literature DB >> 3737130

Congenital pupillary-iris-lens membrane with goniodysgenesis (a new entity).

G W Cibis, J M Waeltermann, E Hurst, R C Tripathi, W Richardson.   

Abstract

We encountered two clinically similar but genetically unrelated cases of a disorder characterized by an unusual white pupillary-iris-lens membrane with extension to a prominent Schwalbe's line, the membranes were vascularized and their appearance changed over time. In both cases the abnormality was unilateral. Anomalous chamber angles were seen on gonioscopy. The clinical appearance is similar to a combination of iridogoniodysgenesis and pupillary membrane. However, our two cases are unique and fit into neither category. We postulate that this is a new entity consisting of an anomalous chamber angle and iris-lens membrane resulting from a localized iris (pupillary membrane), infarct with secondary neovascularization, during formation of the chamber angle.

Entities:  

Mesh:

Year:  1986        PMID: 3737130     DOI: 10.1016/s0161-6420(86)33659-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Fibrous congenital iris membranes with pupillary distortion.

Authors:  R M Robb
Journal:  Trans Am Ophthalmol Soc       Date:  2001

2.  Congenital fibrovascular pupillary membranes: clinical and histopathologic findings.

Authors:  Scott R Lambert; Edward G Buckley; Phoebe D Lenhart; Qing Zhang; Hans E Grossniklaus
Journal:  Ophthalmology       Date:  2011-12-22       Impact factor: 12.079

3.  Congenital fibrovascular pupillary membranes: case series with pathological correlation and surgical treatment.

Authors:  Yi Zhou; Cong Fan; Xiao-Bo Xia; Jian Jiang
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

4.  Congenital fibrovascular pupillary membrane.

Authors:  Mauro Waiswol; Fábio Ejzenbaum; Davi Chen Wu; Eduardo Kagohara; José Ricardo de Abreu Reggi
Journal:  Einstein (Sao Paulo)       Date:  2015-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.